SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jelic V, Johansson S, Almkvist O, et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging. 2000; 21: 533540.
  • 2
    Meyers C, Hess K, Yung W, Levin V. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000; 18: 646650.
  • 3
    Peyser J, Rao S, LaRocca N, Kaplan E. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol. 1990; 47: 9497.
  • 4
    Archibald Y, Lunn D, Ruttan L, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg. 1994; 80: 247253.
  • 5
    Giovagnoli A, Boiardi A. Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci. 1994; 15: 481488.
  • 6
    Anderson S, Damasio H, Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol. 1990; 47: 397405.
  • 7
    Hom J, Reitan R. Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms. J Clin Neuropsychol. 1984; 6: 309324.
  • 8
    Scheibel R, Meyers C, Levin V. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location and treatment. J Neurooncol. 1996; 30: 6169.
  • 9
    Beatty W, Goodkin D, Hertsgaard D, Monson N. Clinical and demographic predictors of cognitive performance in multiple sclerosis. Arch Neurol. 1990; 47: 305308.
  • 10
    Grossman M, Armstrong C, Onishi K, et al. Patterns of cognitive impairment in relapsing-remitting and chronic progressive multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol. 1994; 7: 194210.
  • 11
    Wishart H, Sharpe D. Neuropsychological aspects of multiple sclerosis: a quantitative review. J Clin Exp Neuropsychol. 1996; 19: 810824.
  • 12
    Fischer J, Priore R, Jacobs L, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol. 2000; 48: 885892.
  • 13
    Kieburtz K, Ketonen L, Cox C, et al. Cognitive performance and regional brain volume in human immunodeficiency virus type I infection. Arch Neurol. 1996; 53: 155158.
  • 14
    Reischies F, Hellweg R. Prediction of deterioration in mild cognitive disorder in old age - neuropsychological and neurochemical parameters of dementia diseases. Compr Psychiatry. 2000; 41: 6675.
  • 15
    Armstrong C, Ruffer J, Corn B, DeVries K, Mollman J. Biphasic patterns of memory deficits following moderate dose/partial brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol. 1995; 13: 22632271.
  • 16
    Armstrong C, Corn B, Ruffer J, Pruitt A, Mollman J, Phillips P. Radiotherapeutic effects on brain function: double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol. 2000; 13: 101111.
  • 17
    Armstrong C. Selective versus sustained attention: a continuous performance test revisited. Clin Neuropsychol. 1997; 11: 1833.
  • 18
    Loong J. The continuous performance test. San Luis Obispo, CA: Wang Neuropsychological Laboratory; 1991.
  • 19
    Vanier M, Gauthier L, Lambert J, et al. Evaluation of left visuospatial neglect: norms and discrimination power of two tests. Neuropsychology. 1990; 4: 8796.
  • 20
    Lezak M. Neuropsychological assessment, 3rd ed. New York: Oxford University Press; 1995.
  • 21
    Gronwall D. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977; 44: 367373.
  • 22
    Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press; 1991.
  • 23
    Vitevitch MS, Luce PA, Charles-Luce J, Kemmerer D. Phonotactics and syllable stress: implications for the processing of spoken nonsense words. Lang Speech. 1997; 40: 4762.
  • 24
    Goldstein B, Armstrong CL, Modestino E, Ledakis GE, John C, Hunter JV. Picture and word recognition memory in adult intracranial tumor patients. Brain Cogn. In press.
  • 25
    Benton A. Revised visual retention test: clinical and experimental application, 4th ed. San Antonio, TX: The Psychological Corporation, 1974.
  • 26
    Drachman D, Glosser G, Fleming P, Longenecker G. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology. 1982; 32: 944950.
  • 27
    Glosser G, Goodglass H, Biber C. Assessing visual memory disorders. Psychol Assess Jour Consul Clin Psychol. 1989; 1: 8289.
  • 28
    Armstrong C, Cloud B. The emergence of spatial rotation deficits in dementia and normal aging. Neuropsychology. 1998; 12: 208217.
  • 29
    Money J, Alexander D, Walker HJ. A standardized Road Map Test of direction sense. Baltimore: Johns Hopkins Press; 1965.
  • 30
    Grimsley G, Ruch FL, Warren ND, Ford JS. Employee aptitude survey. Los Angeles: Psychological Services, Inc.; 1956.
  • 31
    Armstrong C, Seebauer E. A test of written expression. Arch Clin Neuropsychol. 1990; 5: 154a.
  • 32
    Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The fatigue severity scale. Arch Neurol. 1989; 46: 11211123.
  • 33
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psych. 1961; 4: 5363.
  • 34
    Klerman GL, Weissman MM, Rousanville BJ, Chevron ES. Interpersonal psychotherapy of depression. New York: Basic Books; 1984: 223244.
  • 35
    Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index—Cancer: development and validation. J Clin Onc. 1984; 2: 472483.
  • 36
    van Buchem M, Grossman R, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology. 1998; 50: 16091617.
  • 37
    Cox D. Regression models and life tables (with discussion). J R Stat Soc [Ser B]. 1972; 34: 187220.
  • 38
    Goldman W, Price J, Storandt M, et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 2001; 56: 361367.
  • 39
    Machieux F, Fenelon G, Flahault A, Manifacier M, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiat. 1998; 64: 178183.
  • 40
    Hall R, Whaley R, Robertson K, Hamby SJW, Hall C. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology. 1996; 46: 16971702.
  • 41
    Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV. Neuropsychiatry Neuropsychol Behav Neurol. 1996; 9: 8390.